Synthesis of the Data on COVID-19 Skin Manifestations: Underlying Mechanisms and Potential Outcomes by Farinazzo E, Dianzani C, Zalaudek I, Conforti C, Grabbe S, Goldust M

Get full text

Eruptive epidermoidzysten nach imiquimod-therapie eines rezidivierenden basalzellkarzinoms by Woltsche, N, El-Shabrawi-Caelen, L, Deinlein, T, Kupsa, R, Gschwandtner, M, Hofmann-Wellenhof, R, Zalaudek, I

Diagnosis and treatment of basal cell carcinoma: European consensus-based interdisciplinary guidelines by Peris, K, Fargnoli, MC, Garbe, C, Kaufmann, R, Bastholt, L, Seguin, NB, Bataille, V, Marmol, VD, Dummer, R, Harwood, CA, Hauschild, A, Höller, C, Haedersdal, M, Malvehy, J, Middleton, MR, Morton, CA, Nagore, E, Stratigos, AJ, Szeimies, RM, Tagliaferri, L, Trakatelli, M, Zalaudek, I, Eggermont, A, Grob, JJ, European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC)

Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study by Russo F, Galluzzo M, Stingeni L, Persechino S, Zichichi L, Conti A, Giofrè C, Dini V, Vispi M, Atzori L, Cattaneo A, Parodi A, Bardazzi F, Stinco G, Dapavo P, Girolomoni G, Musumeci ML, Papini M, Venturini M, Dastoli S, Di Nuzzo S, Fargnoli MC, Pagnanelli G, Bernardini N, Gambini DM, Malagoli P, Mazzatenta C, Peris K, Zalaudek I, Fabbrocini G, Loconsole F, Vassallo C, Pietroleonardo L, Prignano F, Franchi C, Offidani AM, Bonifati C, Di Lernia V, Gigante G, Bartezaghi MS, Franchi M, Ursoleo P, Aloisi E

Get full text